Physician profile
Venkat Modukuru
NPI 1841621752
$14,948.18
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $13.90 · 2021: $122 · 2022: $166 · 2023: $13K · 2024: $1,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Food and Beverage: $1,333 · Travel and Lodging: $540 · Gift: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,539.59 |
| Food and Beverage | $1,333.40 |
| Travel and Lodging | $539.68 |
| Gift | $107.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,350.14 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $648.26 | 2021-2024 | Ligasure, Signia |
| Davol INC. | $310.88 | 2023-2024 | Phasix Mesh, Arista Ah Flexitip |
| Baxter Healthcare | $212.17 | 2023 | Floseal |
| Tela Bio, INC. | $142.96 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kci USA, INC. | $125.00 | 2019 | |
| Novo Nordisk INC | $77.37 | 2023 | Wegovy |
| Next Science LLC | $67.50 | 2023 | Xperience, Blastx, Surgx |
| W. L. Gore & Associates, INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkat Modukuru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.